Anna Fakhardo

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis.

|Sep 07, 2022
Heparin-coated iron oxide nanoparticles: application as a liver contrast agent, toxicity and pharmacokinetics.

Anna Fakhardo, Elizaveta Anastasova, Victor Makarov

|Jan 13, 2022
Toxicity Patterns of Clinically Relevant Metal Oxide Nanoparticles.

Anna F Fakhardo, Elizaveta I Anastasova, Sabina R Gabdullina

|Oct 29, 2021
Hafnium Oxide-Based Nanoplatform for Combined Chemoradiotherapy.

Anastasiia A Sherstiuk, Sergey A Tsymbal, Anna F Fakhardo

|Apr 15, 2020
Effects of Metal Oxide Nanoparticles on Toll-Like Receptor mRNAs in Human Monocytes.

Vladislav A Vasilichin, Sergey A Tsymbal, Anna F Fakhardo

Pageof 1

Frequent Collaborators

2 joint publications

Vladimir V Vinogradov

2 joint publications

Elena I Koshel

2 joint publications

Elena F Krivoshapkina

2 joint publications

Pavel V Krivoshapkin